If you or a family member is coming home from the Democratic Republic of the Congo, Uganda, or South Sudan this summer, a public health worker will probably contact you. Most people this happens to will have had no exposure to anyone with Ebola. The contact is not an accusation, and it is not a quarantine. Knowing what it actually involves is the difference between cooperating and ignoring an unfamiliar phone number.
The CDC has published interim guidance for state, tribal, local and territorial health departments on how to conduct post-arrival public health assessment and management of travelers arriving from countries affected by the 2026 outbreak of Bundibugyo virus disease. The guidance is written for health departments, but it describes a process that lands on ordinary households, and it reflects evidence current as of July 7.
The outbreak behind it is the largest of its kind ever recorded. The DRC reported 2,905 confirmed cases and 1,269 related deaths as of July 23, according to the European Centre for Disease Prevention and Control, with Ituri Province accounting for the large majority. No cases have been identified in the United States.
What Post-Arrival Assessment Involves
The guidance draws a sharp line that most coverage of this outbreak has blurred. It applies to travelers who have no identified high-risk exposures. People with high-risk exposures, and anyone with suspected or confirmed Bundibugyo virus disease, fall under a separate and considerably more restrictive federal framework.
For the ordinary traveler, the process starts before anyone calls. CDC provides contact information for arriving travelers electronically to health departments daily, generated through the entry screening program that routes affected arrivals through designated airports.
The health department then conducts an exposure assessment. The questions are specific rather than general. Did the traveler have any epidemiologic risk factors for exposure to Bundibugyo virus? Any physical contact with a person who had the disease or with their body fluids, including as a caregiver, health care provider, laboratory worker or burial worker? Were personal protective equipment and recommended infection control measures used during any potential exposure? Were there potential zoonotic exposures?
That assessment determines what follows, and for the great majority of travelers what follows is education and self-monitoring rather than restriction. The traveler is told what symptoms to watch for, given 24-hour contact information, and asked to report if anything develops within 21 days of leaving the affected country.
The 21-day figure is the outer edge of the incubation period, which is why it governs both the monitoring window and decisions about testing.
Why This Matters More Than a Case Count
MedicalDaily has reported extensively on this outbreak, including the third consecutive 30-day renewal of U.S. entry restrictions keeping screening active through approximately August 12, and the death toll passing 1,000 in the fastest-spreading outbreak on record. Those reports answered how bad it is and what the government is doing.
This guidance answers a different question, and it is the one that matters to an actual household: what happens to me, and what am I supposed to do?
The population involved is not small or exotic. It includes humanitarian and medical aid workers, missionaries, mining and construction personnel, journalists, students, researchers, and members of Congolese and Ugandan diaspora communities traveling for family reasons. Two U.S. citizens working in the DRC have already tested positive and been medically evacuated to Germany, and France reported an imported case in June.
South Sudan is included in the guidance not because cases have been identified there but because it borders the DRC with high-volume travel across a porous shared border. That is a precautionary inclusion, and travelers from South Sudan should expect to be contacted even though no specific area of concern has been identified.
What Makes This Virus Different
The clinical reality shapes why the monitoring window is taken so seriously. Bundibugyo virus disease is a viral hemorrhagic fever and a type of Ebola disease. CDC states plainly that "no vaccines or specific treatments have been approved" to prevent or treat it, and that early supportive care improves the chance of survival.
That last clause is the entire argument for the guidance. The two licensed Ebola vaccines target the Zaire species and are not established as protective against Bundibugyo. There is no course of pills to take. What changes outcomes is being identified early enough for aggressive fluid and electrolyte management, treatment of complications, and isolation before further transmission occurs.
Early symptoms are nonspecific and overlap heavily with common travel illnesses, which is the practical difficulty. Fever, severe headache, muscle pain, fatigue, sore throat, then vomiting, diarrhea and abdominal pain. Malaria is far more likely in a returning traveler from this region, which is why the CDC has advised clinicians to consider malaria testing in patients suspected of having a viral hemorrhagic fever after arriving from an affected area.
The virus does not spread through the air. Transmission requires direct contact with blood or body fluids of a symptomatic person or with contaminated objects, or contact with infected animals. A person who is not symptomatic is not contagious.
What Travelers and Their Families Should Do
Anyone returning from an affected country should answer the health department's call and keep the contact number they are given. Take your temperature twice daily during the 21-day window if asked to, and record it.
Report any fever or the symptoms listed above to the health department contact first, before going to a clinic or emergency department. This is the step that most protects both the traveler and the health system, because it allows the facility to prepare isolation and testing rather than being surprised at a triage desk. If symptoms are severe enough to require emergency care, call ahead or tell dispatch about the travel history.
For household members, the monitoring window does not require separation from a traveler who has no symptoms and no high-risk exposure. Everyday household contact with an asymptomatic person does not transmit this virus.
Anyone planning travel to the region should check CDC travel health notices before departure, since notice levels and entry measures have changed repeatedly during this outbreak.
What Happens Next
Entry restrictions have been renewed in 30-day increments, and the current order runs to approximately August 12. Uganda discharged its last confirmed patient in mid-July and began the 42-day countdown required before an outbreak can be declared over there, though the DRC outbreak continues to grow.
The interim guidance is explicitly labeled interim and may be revised as evidence changes. The newest confirmed fact is that federal guidance now sets out a defined assessment and 21-day self-monitoring process for travelers without high-risk exposures. The people most affected are aid workers and diaspora families returning from three countries. The most reasonable action is answering the phone and keeping the number. The central uncertainty is how long the outbreak, and therefore the screening program, will continue.
Frequently Asked Questions
Who does this guidance apply to? Travelers arriving in the United States from countries affected by the 2026 Ebola outbreak who have no identified high-risk exposures. People with high-risk exposures or suspected disease fall under separate, stricter federal guidance.
Will I be quarantined? The guidance for travelers without high-risk exposures centers on exposure assessment, education, and symptom self-monitoring rather than restriction of movement.
How long does monitoring last? Twenty-one days after leaving the affected country, which reflects the outer limit of the incubation period.
What symptoms should I report? Fever, severe headache, muscle pain, fatigue, sore throat, vomiting, diarrhea, or abdominal pain. Report to your health department contact before going to a clinic.
Is there a vaccine or treatment? No. CDC states no vaccines or specific treatments have been approved for Bundibugyo virus disease. Early supportive care improves survival.
Can I catch it from someone who feels fine? No. Transmission requires direct contact with blood or body fluids of a symptomatic person, contaminated objects, or infected animals. It does not spread through the air.
Why is South Sudan included? Because it borders the DRC with high-volume travel across a porous shared border, not because a specific area of concern has been identified there.
